[Federal Register Volume 69, Number 92 (Wednesday, May 12, 2004)]
[Notices]
[Page 26408]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10798]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 24, 2003, and published in the Federal 
Register on January 27, 2004, (69 FR 3946), Noramco, Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by renewal to the Drug 
Enforcement Administration for registration as a bulk manufacturer of 
the basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Noramco, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco, Inc. to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed is granted.

    Dated: April 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-10798 Filed 5-11-04; 8:45 am]
BILLING CODE 4410-09-M